• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的社会人口学及临床特征

Socio-demographic and clinical aspects of rheumatoid arthritis.

作者信息

Owino B O, Oyoo G O, Otieno C F

机构信息

Kenyatta National Hospital, P.O. Box 20723-00202, Nairobi, Kenya.

出版信息

East Afr Med J. 2009 May;86(5):204-11. doi: 10.4314/eamj.v86i5.54190.

DOI:10.4314/eamj.v86i5.54190
PMID:20084988
Abstract

OBJECTIVE

To determine the socio-demographic profiles and some clinical aspects of patients with rheumatoid arthritis (RA).

DESIGN

Prospective, cross-sectional study.

SETTING

Ambulatory out- patient clinics of Kenyatta National Hospital (KNH), a public national and referral hospital.

SUBJECTS

Out of 180 patients interviewed and examined, 60 met American College of Rheumatology (ACR) diagnostic criteria of RA.

RESULTS

Of the 60 patients recruited 52 (87%) were females with male: female ratio of 1: 6.5. The mean age of patients was 41.38(+/- 16.8) years. There were two peaks of age of occurrence, 20-29 and 40-49 years. In 75% of the study patients, one or more of metacarpophalangeal joints of the hand were involved in the disease. Other frequently involved sites were--wrists, elbows, knees, ankles and glenohumeral joints of shoulders in a symmetrical manner. Serum rheumatoid factor was positive in 78.9% while rheumatoid nodules were present in 13.3% of the study patients. A large majority of patients (88%) had active disease with 18% having mild disease, 38% moderate activity and 32% having severe disease. Only 12% of patients had disease in remission. Forty six point seven per cent (46.7%) of the study patients were on at least one Disease Modifying anti Rheumatic Drugs (DMARD) from a selection of methotrexate, sulphasalazine, hydroxychloroquine and leflunamide. The most frequent drug combination was methotrexate plus prednisolone at 30% of the study population; while 66.7% were on oral prednisolone with 25% of the study patients taking only Non-Steroidal anti Inflammatory Drugs (NSAIDS).

CONCLUSION

A large majority of ambulatory patients with RA had active disease. Most of them were sub-optimally treated, especially the use of DMARDS. About two thirds were on oral steroids. Sub-optimal therapy in relatively young patients, peak 20-29 and 40-49 years is likely to impact negatively on their disease control and quality of life.

摘要

目的

确定类风湿关节炎(RA)患者的社会人口统计学特征及一些临床方面情况。

设计

前瞻性横断面研究。

地点

肯尼亚国家医院(KNH)的门诊诊所,这是一家国立公立转诊医院。

研究对象

在接受访谈和检查的180例患者中,60例符合美国风湿病学会(ACR)的RA诊断标准。

结果

招募的60例患者中,52例(87%)为女性,男女比例为1:6.5。患者的平均年龄为41.38(±16.8)岁。发病年龄有两个高峰,分别为20 - 29岁和40 - 49岁。在75%的研究患者中,手部的一个或多个掌指关节受累。其他常见受累部位依次为——手腕、肘部、膝盖、脚踝以及肩部的肩肱关节,呈对称性。血清类风湿因子阳性率为78.9%,类风湿结节在13.3%的研究患者中出现。绝大多数患者(88%)患有活动性疾病,其中18%为轻度疾病,38%为中度活动,32%为重度疾病。只有12%的患者疾病处于缓解期。46.7%的研究患者至少使用了一种改变病情抗风湿药(DMARD),药物选择包括甲氨蝶呤、柳氮磺胺吡啶、羟氯喹和来氟米特。最常见的药物组合是甲氨蝶呤加泼尼松龙,占研究人群的30%;66.7%的患者使用口服泼尼松龙,25%的研究患者仅服用非甾体抗炎药(NSAIDS)。

结论

绝大多数门诊RA患者患有活动性疾病。他们中的大多数治疗未达最佳效果,尤其是DMARDs的使用。约三分之二的患者使用口服类固醇。相对年轻患者(发病高峰在20 - 29岁和40 - 49岁)治疗未达最佳可能会对其疾病控制和生活质量产生负面影响。

相似文献

1
Socio-demographic and clinical aspects of rheumatoid arthritis.类风湿关节炎的社会人口学及临床特征
East Afr Med J. 2009 May;86(5):204-11. doi: 10.4314/eamj.v86i5.54190.
2
[Disease-modifying treatment for inflammatory rheumatism in sub-Saharan Africa: outcome at 6 months of 205 Senegalese patients with rheumatoid arthritis].[撒哈拉以南非洲地区炎性风湿病的病情改善治疗:205例塞内加尔类风湿关节炎患者6个月时的结局]
Med Sante Trop. 2012 Oct-Dec;22(4):385-9. doi: 10.1684/mst.2012.0096.
3
Remission assessment of rheumatoid arthritis in daily practice in China: a cross-sectional observational study.中国日常实践中的类风湿关节炎缓解评估:一项横断面观察性研究。
Clin Rheumatol. 2018 Mar;37(3):597-605. doi: 10.1007/s10067-017-3850-z. Epub 2017 Nov 7.
4
Characteristics of patients with rheumatoid arthritis in Qatar: a cross-sectional study.卡塔尔类风湿性关节炎患者的特征:一项横断面研究。
Int J Rheum Dis. 2014 Jan;17(1):63-5. doi: 10.1111/1756-185X.12135. Epub 2013 Jul 16.
5
Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.四分之三未使用改善病情抗风湿药物的类风湿关节炎患者在12个月时达到28个关节疾病活动评分缓解:芬兰类风湿关节炎队列研究结果
Scand J Rheumatol. 2017 Nov;46(6):425-431. doi: 10.1080/03009742.2016.1266029. Epub 2017 Apr 3.
6
Databases of patients with early rheumatoid arthritis in the USA.美国早期类风湿性关节炎患者数据库。
Clin Exp Rheumatol. 2003 Sep-Oct;21(5 Suppl 31):S146-53.
7
Clinical profile of 266 Filipino patients with rheumatoid arthritis included in the rheumatoid arthritis database and registry (RADAR) of the Philippine General Hospital.纳入菲律宾总医院类风湿关节炎数据库与登记处(RADAR)的266例菲律宾类风湿关节炎患者的临床概况。
Int J Rheum Dis. 2015 May;18(4):433-8. doi: 10.1111/1756-185X.12273. Epub 2014 Feb 7.
8
How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.类风湿关节炎的初始治疗应采取何种积极程度?与“非积极”改善病情抗风湿药治疗反应相关的因素及一项为期两年的开放标签试验的观点
Rheumatology (Oxford). 2004 May;43(5):619-25. doi: 10.1093/rheumatology/keh135. Epub 2004 Feb 24.
9
The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.使用传统抗风湿病情缓解药物联合治疗的良好初始反应会随着时间持续:芬兰类风湿关节炎联合治疗试验的11年结果
Arthritis Rheum. 2009 May;60(5):1222-31. doi: 10.1002/art.24447.
10
Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study.影响类风湿关节炎患者缓解的因素:卡纳塔克邦类风湿关节炎合并症(KRAC)研究结果
Int J Rheum Dis. 2018 Nov;21(11):1977-1985. doi: 10.1111/1756-185X.12908. Epub 2016 Jul 25.

引用本文的文献

1
Prevalence, Clinical Manifestations, and Treatment Pattern of Patients with Rheumatoid Arthritis Attending the Rheumatology Clinic at Tikur Anbessa Specialized Hospital, Ethiopia: A Cross-Sectional Study.埃塞俄比亚提库尔安贝萨专科医院风湿病门诊类风湿关节炎患者的患病率、临床表现及治疗模式:一项横断面研究
Open Access Rheumatol. 2022 Oct 14;14:221-229. doi: 10.2147/OARRR.S383778. eCollection 2022.
2
Evaluation of prescription practices in rheumatoid arthritis at the rheumatology clinic in a tertiary care teaching hospital in Uttarakhand: A cross-sectional study.北阿坎德邦一家三级护理教学医院风湿科门诊类风湿关节炎处方实践的评估:一项横断面研究。
J Family Med Prim Care. 2021 Feb;10(2):745-751. doi: 10.4103/jfmpc.jfmpc_1366_20. Epub 2021 Feb 27.
3
Rheumatic diseases in Africa.非洲的风湿性疾病。
Nat Rev Rheumatol. 2021 Jun;17(6):363-374. doi: 10.1038/s41584-021-00603-4. Epub 2021 Apr 13.
4
Rheumatology care of migrants from sub-Saharan Africa: a literature review and qualitative pilot study of patients' perspectives.撒哈拉以南非洲移民的风湿病护理:文献综述和患者观点的定性试点研究。
Clin Rheumatol. 2021 Sep;40(9):3429-3438. doi: 10.1007/s10067-020-05099-z. Epub 2020 Apr 25.
5
Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey.纬度梯度影响类风湿关节炎的发病年龄:一项全球调查。
Clin Rheumatol. 2017 Mar;36(3):485-497. doi: 10.1007/s10067-016-3481-9. Epub 2016 Dec 19.
6
Reliable and cost-effective serodiagnosis of rheumatoid arthritis.类风湿关节炎的可靠且经济高效的血清学诊断
Rheumatol Int. 2016 Jun;36(6):751-8. doi: 10.1007/s00296-016-3433-3. Epub 2016 Feb 9.
7
Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution?中东和非洲类风湿关节炎治疗不理想:EULAR 推荐意见能否成为解决方案的起点?
Clin Rheumatol. 2013 Feb;32(2):151-9. doi: 10.1007/s10067-012-2153-7. Epub 2012 Dec 30.
8
A phase I trial to evaluate the safety and pharmacokinetics of low-dose methotrexate as an anti-malarial drug in Kenyan adult healthy volunteers.一项评估低剂量甲氨蝶呤作为抗疟药物在肯尼亚成年健康志愿者中的安全性和药代动力学的 I 期临床试验。
Malar J. 2011 Mar 16;10:63. doi: 10.1186/1475-2875-10-63.